erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
sponsored by an innovative medicines canada company
.
lawmakers should revisit that idea when lepage is no longer in office next year.
.
"this should not have happened and should never be allowed to happen again to another vulnerable person or their family.
.
.